Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Michael F. Orr, Andrew H. Rogers, Justin M. Shepherd, Julia D. Buckner, Joseph W. Ditre, Jafar Bakhshaie & Michael J. Zvolensky. (2020) Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain?. Psychology, Health & Medicine 25:6, pages 742-755.
Read now
Read now
Mallory Loflin, Kimberly Babson, Kendall Browne & Marcel Bonn-Miller. (2018) Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. The American Journal of Drug and Alcohol Abuse 44:1, pages 19-23.
Read now
Read now
Cristina Casajuana, Hugo López-Pelayo, María Mercedes Balcells, Laia Miquel, Joan Colom & Antoni Gual. (2016) Definitions of Risky and Problematic Cannabis Use: A Systematic Review. Substance Use & Misuse 51:13, pages 1760-1770.
Read now
Read now
Corina Aguilar-Raab, Moritz Heene, Dennis Grevenstein & Jan Weinhold. (2015) Assessing Drug Consumption Behavior With the Heidelberger Drogenbogen (Heidelberg Drug Scales): Reliabilities, Validities, and Cut-Off Criteria. Substance Use & Misuse 50:13, pages 1638-1649.
Read now
Read now
Cameron Duff & Patricia G. Erickson. (2014) Cannabis, risk and normalisation: evidence from a Canadian study of socially integrated, adult cannabis users. Health, Risk & Society 16:3, pages 210-226.
Read now
Read now
Articles from other publishers (18)
Arturo Alvarez-Roldan, Iván Parra & Víctor J. Villanueva-Blasco. (2022) Attitudes Toward Cannabis of Users and Non-users in Spain: a Concept Mapping Study Among University Students. International Journal of Mental Health and Addiction 21:6, pages 3952-3970.
Crossref
Crossref
Fathima Fataar, Pete Driezen, Akwasi Owusu‐Bempah & David Hammond. (2023) Patterns of problematic cannabis use in Canada pre‐ and post‐legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity. Drug and Alcohol Review.
Crossref
Crossref
Michael F. Orr, Luke F. Heggeness, Nirvi Mehta, Jacob Moya, Kara Manning, Lorra Garey, Julianna Hogan, Marcel de Dios & Michael J. Zvolensky. (2023) Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder. Addictive Behaviors 137, pages 107509.
Crossref
Crossref
Ferdinand M. Adounkpe, Luc Behanzin, Bienvenu S. Adehan, Marc Medehouenou, Ornella Daoudou, Assad Bio-Sya, Odile Kougblenou, Arnaud Agbanlinsou & Clément Agbangla. (2022) Problematic Use of Cannabis in Cotonou: Profile of Some Subjects Received in the Laboratory between 2016 and 2021. Journal of Addiction 2022, pages 1-9.
Crossref
Crossref
Christophe Huỳnh, Alexis Beaulieu‐Thibodeau, Jean‐Sébastien Fallu, Jacques Bergeron, Alain Jacques & Serge Brochu. (2022) Typologies of Canadian young adults who drive after cannabis use: A two‐step cluster analysis. Behavioral Sciences & the Law 40:2, pages 310-330.
Crossref
Crossref
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J. Budney & Wayne D. Hall. (2021) Cannabis use and cannabis use disorder. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Danielle Amiet, George J. Youssef, Lauryn J. Hagg, Valentina Lorenzetti, Linden Parkes, Nadia Solowij & Murat Yücel. (2020) Young Adults With Higher Motives and Expectancies of Regular Cannabis Use Show Poorer Psychosocial Functioning. Frontiers in Psychiatry 11.
Crossref
Crossref
L. Artigaud, C. Fener, M. Bisch, R. Schwan, T. Schwitzer, J. De Ternay, S.J. Adamson, B. Rolland & V. Laprévote. (2020) Les outils de repérage pour les troubles de l’usage du cannabis et leur adaptation au DSM-5 : une revue de littérature. L'Encéphale 46:5, pages 382-389.
Crossref
Crossref
Sharon R. Sznitman & Robin Room. (2018) Rethinking indicators of problematic cannabis use in the era of medical cannabis legalization. Addictive Behaviors 77, pages 100-101.
Crossref
Crossref
Henrik Jungaberle, Nils Biedermann, Julia Nott, Andrea Zeuch & Maximilian von Heyden. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
175
196
.
Andrew Tuck, Hayley A. Hamilton, Branka Agic, Anca R. Ialomiteanu & Robert E. Mann. (2017) Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario. Drug and Alcohol Dependence 179, pages 93-99.
Crossref
Crossref
Sharon R. Sznitman. (2017) Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?. International Journal of Drug Policy 42, pages 15-21.
Crossref
Crossref
B. Annaheim & S. Legleye. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
e168
e184
.
Henrik Jungaberle, Nils Biedermann, Julia Nott, Andrea Zeuch & Maximilian von Heyden. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
23
.
H. López-Pelayo, A. Batalla, M. M. Balcells, J. Colom & A. Gual. (2014) Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychological Medicine 45:6, pages 1121-1133.
Crossref
Crossref
Mark Asbridge, Cameron Duff, David C. Marsh & Patricia G. Erickson. (2014) Problems with the Identification of ‘Problematic' Cannabis Use: Examining the Issues of Frequency, Quantity, and Drug Use Environment. European Addiction Research 20:5, pages 254-267.
Crossref
Crossref
Patricia G. Erickson. (2011) Lower Risk Cannabis Use Guidelines: For Whom?. Canadian Journal of Public Health 102:5, pages 328-329.
Crossref
Crossref
Oskar H. Sommer, Olav Aga, Milada Cvancarova, Inge C. Olsen, Geir Selbaek & Knut Engedal. (2009) Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia. Dementia and Geriatric Cognitive Disorders 27:2, pages 155-163.
Crossref
Crossref